1 00:00:05,034 --> 00:00:06,802 HELLO, EVERYONE. WELCOME TO 2 00:00:06,802 --> 00:00:15,511 THE TECHNICAL ASSISTANCE 3 00:00:15,511 --> 00:00:20,115 WEBINAR. FOR HFAHD2407. A FEW 4 00:00:20,115 --> 00:00:21,617 HOUSEKEEPING ITEMS. PLEASE KNOW 5 00:00:21,617 --> 00:00:23,152 THIS MEETING IS BEING RECORDED. 6 00:00:23,152 --> 00:00:24,787 IF YOU EXPERIENCE ANY TECHNICAL 7 00:00:24,787 --> 00:00:27,556 ISSUES YOU CAN CHAT TO THE HOST 8 00:00:27,556 --> 00:00:30,292 BY PUTTING A MESSAGE IN THE CHAT 9 00:00:30,292 --> 00:00:38,333 OR E-MAIL AND JUST PLEASE PUT 10 00:00:38,333 --> 00:00:44,173 TECH SUPPORT IN THE E-MAIL 11 00:00:44,173 --> 00:00:48,644 SUBJECT LINE. AND TO POSE 12 00:00:48,644 --> 00:00:50,646 QUESTIONS DURING THE Q&A YOU CAN 13 00:00:50,646 --> 00:00:52,915 SELECT THE Q&A BUTTON IN THE 14 00:00:52,915 --> 00:00:55,417 TASK BAR OF YOUR SCREEN AND YOU 15 00:00:55,417 --> 00:00:58,120 SIMPLY ENTER YOUR QUESTION INTO 16 00:00:58,120 --> 00:01:05,360 THE Q&A PANEL AND THEN SELECT 17 00:01:05,360 --> 00:01:07,930 SEND. THE SELECT SEND BUTTON. 18 00:01:07,930 --> 00:01:13,168 ALL QUESTIONS CAN BE VIEWED BY 19 00:01:13,168 --> 00:01:17,272 THE PANELISTS. YOU CLICK THE 20 00:01:17,272 --> 00:01:22,077 CAPTION ON YOUR TASK BAR. CLICK 21 00:01:22,077 --> 00:01:23,512 CAPTION BUTTON. PULL THE DOT ON 22 00:01:23,512 --> 00:01:29,051 THE SLIDER TO ADJUST THE SIZE OF 23 00:01:29,051 --> 00:01:32,654 CAPTIONING. ADDITIONAL 24 00:01:32,654 --> 00:01:35,357 REMINDERS, PARTICIPATION IS 25 00:01:35,357 --> 00:01:36,024 OPTIONAL AND IS NOT REQUIRED TO 26 00:01:36,024 --> 00:01:39,027 APPLY TO THE RFA. THE WEBINAR 27 00:01:39,027 --> 00:01:41,530 IS BEING RECORDED AND WE WILL 28 00:01:41,530 --> 00:01:43,098 SHARE THE RECORDING WITH 29 00:01:43,098 --> 00:01:46,368 REGISTRANTS BY E-MAIL. 30 00:01:46,368 --> 00:01:46,935 PANELISTS, PRESENTERS WILL 31 00:01:46,935 --> 00:01:50,672 ANSWER QUESTIONS AS TIME 32 00:01:50,672 --> 00:01:54,777 PERMITS. MY NAME IS TOYIN 33 00:01:54,777 --> 00:01:59,515 AJISAFE, I'M A PROGRAM OFFICER. 34 00:01:59,515 --> 00:02:02,284 FOR VISUAL DESCRIPTION I'M 35 00:02:02,284 --> 00:02:05,320 MIDDLE AGED MALE WITH DARK BROWN 36 00:02:05,320 --> 00:02:08,423 SKIN AND BRACHYHAIR. AND GRAY 37 00:02:08,423 --> 00:02:13,862 GOATEE. TODAY I'M WEARING A 38 00:02:13,862 --> 00:02:17,900 WHITE LONG SLEEVE SHIRT. I DO 39 00:02:17,900 --> 00:02:23,005 NOT HAVE ANY DISCLOSURES. TODAY 40 00:02:23,005 --> 00:02:25,774 I'M EXCITED TO BE JOINED BY THE 41 00:02:25,774 --> 00:02:27,009 DIRECTOR OF THE NATIONAL CENTER 42 00:02:27,009 --> 00:02:31,013 FOR MEDICAL REHABILITATION 43 00:02:31,013 --> 00:02:32,815 RESEARCH DR. TERESA CRUS AND I 44 00:02:32,815 --> 00:02:35,150 WANT TO KNOW THAT THIS IS 45 00:02:35,150 --> 00:02:36,618 ACTUALLY HER BRAIN CHILD AND I'M 46 00:02:36,618 --> 00:02:38,420 THRILLED THAT SHE'S ON HAND TO 47 00:02:38,420 --> 00:02:40,355 HELP ANSWER QUESTIONS TODAY. 48 00:02:40,355 --> 00:02:44,193 I'M ALSO JOINED BY CHRISTIAN 49 00:02:44,193 --> 00:02:47,196 ROBINS WHO'S FROM THE NATIONAL 50 00:02:47,196 --> 00:02:48,764 INSTITUTE OF CHILD HEALTH AND 51 00:02:48,764 --> 00:02:52,367 SHE WILL ADDRESS THE REVIEW 52 00:02:52,367 --> 00:02:54,837 SECTION OF THIS PRESENTATION. 53 00:02:54,837 --> 00:02:59,374 FINAL I'M JOINED BY DR. MORIA 54 00:02:59,374 --> 00:03:07,249 BIT TMANN. THE AGENERAL DA, SO 55 00:03:07,249 --> 00:03:10,118 WE'LL BRIEFLY GO OVER THE RFA 56 00:03:10,118 --> 00:03:11,753 BACKGROUND, GO OVER SOME KEY 57 00:03:11,753 --> 00:03:14,089 DEFINITIONS, WE'LL TOUCH ON THE 58 00:03:14,089 --> 00:03:16,458 OBJECTIVES AND EXPECTATIONS. AS 59 00:03:16,458 --> 00:03:19,027 I MENTIONED DR. ROBINS WILL 60 00:03:19,027 --> 00:03:22,030 ADDRESS THE PEER REVIEW. WE'LL 61 00:03:22,030 --> 00:03:23,332 TOUCH ON TIMELINE FOR 62 00:03:23,332 --> 00:03:25,801 SUBMISSION, REVIEW AND SELECTION 63 00:03:25,801 --> 00:03:28,270 OF APPLICATIONS AND THEN FINALLY 64 00:03:28,270 --> 00:03:30,272 WE'LL OPEN UP THE FLOOR FOR 65 00:03:30,272 --> 00:03:31,073 QUESTIONS AND THE PANEL WILL 66 00:03:31,073 --> 00:03:41,617 RESPOND TO THOSE QUESTIONS. RFA 67 00:03:42,084 --> 00:03:43,819 BACKGROUND. SO SOME KEY 68 00:03:43,819 --> 00:03:46,054 DEFINITIONS. ABLEISM IS DEFINED 69 00:03:46,054 --> 00:03:47,789 AS DISCRIMINATION AND SOCIAL 70 00:03:47,789 --> 00:03:52,094 PREJUDICE AGAINST PEOPLE WITH 71 00:03:52,094 --> 00:03:52,694 DISABILITIES. CHARACTERIZES 72 00:03:52,694 --> 00:03:54,429 PEOPLE AND DEFINES PEOPLE BY 73 00:03:54,429 --> 00:03:56,531 THEIR DISABILITIES. CLASSIFIES 74 00:03:56,531 --> 00:04:00,269 DISABLED PEOPLE AS INFERIOR TO 75 00:04:00,269 --> 00:04:02,504 NONDISABLED PEOPLE. ABLEISM MAY 76 00:04:02,504 --> 00:04:05,974 MANIFEST IN THE PHYSICAL 77 00:04:05,974 --> 00:04:08,110 ENVIRONMENT. JUST IN BEHAVIORS. 78 00:04:08,110 --> 00:04:09,912 EXAMPLES ARE INACCESSIBLE 79 00:04:09,912 --> 00:04:12,481 MEDICAL FACILITIES AND 80 00:04:12,481 --> 00:04:18,987 EQUIPMENT. FAILING TO DISCLOSE 81 00:04:19,288 --> 00:04:27,562 REPRODUCTIVE HEALTH BASED ON 82 00:04:27,562 --> 00:04:28,797 ASSUMPTIONS. AND FAIL TO 83 00:04:28,797 --> 00:04:30,732 REPRESENT OR MEANINGFULLY 84 00:04:30,732 --> 00:04:33,535 INCUDOTHE VOICES OF DISABLED 85 00:04:33,535 --> 00:04:36,538 PEOPLE. THESE ARE OFTEN 86 00:04:36,538 --> 00:04:39,107 GROUNDED IN ABLEST BELIEFS AND 87 00:04:39,107 --> 00:04:41,743 PERPETRATE ON DISABLED PEOPLE 88 00:04:41,743 --> 00:04:45,447 AND BENEFIT ABLE-BODIED PEOPLE. 89 00:04:45,447 --> 00:04:47,649 NEXT SLIDE, PLEASE. BOTH 90 00:04:47,649 --> 00:04:48,617 ABLEISM AND STRUCTURAL ABLEISM 91 00:04:48,617 --> 00:04:50,752 ARE INCLUDED IN THIS NOTICE OF 92 00:04:50,752 --> 00:04:52,421 FUNDING OPPORTUNITY. AND FROM 93 00:04:52,421 --> 00:04:55,223 HERE ON OUT I WILL REFER TO THE 94 00:04:55,223 --> 00:04:57,993 NOTICE OF FUNDING OPPORTUNITY AS 95 00:04:57,993 --> 00:05:01,663 A NOFO. FOR THE PURPOSE OF THIS 96 00:05:01,663 --> 00:05:05,033 NOFO DISABILITY IS A DEMOGRAPHIC 97 00:05:05,033 --> 00:05:07,869 CHARACTERISTICS NOT ON OUTCOME 98 00:05:07,869 --> 00:05:09,738 MEASURE. TO TERM PEOPLE WITH 99 00:05:09,738 --> 00:05:10,672 DISABILITIES IS USED THROUGHOUT 100 00:05:10,672 --> 00:05:13,208 THIS NOFO FOR CONSISTENCY, 101 00:05:13,208 --> 00:05:15,544 HOWEVER, WE FULLY ACKNOWLEDGE 102 00:05:15,544 --> 00:05:18,080 THAT THERE ARE PREFERENCES, 103 00:05:18,080 --> 00:05:19,247 DIFFERENCES IN PREFERENCES IN 104 00:05:19,247 --> 00:05:23,752 THE DISABILITIES COMMUNITY. 105 00:05:23,752 --> 00:05:26,321 THIS IS SOME DISABLED PERSON AND 106 00:05:26,321 --> 00:05:28,857 OTHERS PREFER PEOPLE WITH 107 00:05:28,857 --> 00:05:30,625 DISABILITY AND SO BOTH FULL LU 108 00:05:30,625 --> 00:05:33,795 INCLUDED IN THIS NOFO. PEOPLE 109 00:05:33,795 --> 00:05:37,599 WITH LIVED EXPERIENCE ARE THOSE 110 00:05:37,599 --> 00:05:39,101 THAT DIRECTLY AFFECTED BY SOCIAL 111 00:05:39,101 --> 00:05:41,503 HEALTH, PUBLIC HEALTH, OR OTHER 112 00:05:41,503 --> 00:05:42,871 ISSUES AND THE STRATEGIES THAT 113 00:05:42,871 --> 00:05:46,308 AIM TO ADDRESS THOSE ISSUES. 114 00:05:46,308 --> 00:05:47,676 SUCH THAT PEOPLE WITH LIVED 115 00:05:47,676 --> 00:05:50,512 EXPERIENCE HAVE INSIGHTS THAT 116 00:05:50,512 --> 00:05:53,048 CAN REFORM AND IMPROVE SYSTEMS, 117 00:05:53,048 --> 00:05:59,021 RESEARCH, POLICIES, PRACTICES 118 00:05:59,021 --> 00:06:01,790 AND PROGRAMS. PEOPLE WITH 119 00:06:01,790 --> 00:06:03,558 DISABILITIES OFTEN FACE BARRIERS 120 00:06:03,558 --> 00:06:06,228 TO ACCESSING HEALTH CARE. 121 00:06:06,228 --> 00:06:08,797 EXAMPLE IS PHYSICAL BARRIERS, 122 00:06:08,797 --> 00:06:11,366 INACCESSIBLE FACILITIES AND 123 00:06:11,366 --> 00:06:12,534 MEDICAL EQUIPMENT, LACK OF 124 00:06:12,534 --> 00:06:16,705 TRANSPORTATION TO APPOINTMENTS. 125 00:06:16,705 --> 00:06:17,305 PEOPLE WITH DISABILITIES ARE 126 00:06:17,305 --> 00:06:19,007 MORE LIKELY TO EXPERIENCE 127 00:06:19,007 --> 00:06:20,342 CHRONIC HEALTH CONDITIONS. 128 00:06:20,342 --> 00:06:21,910 THEY'RE ALSO LESS LIKELY TO BE 129 00:06:21,910 --> 00:06:25,013 UP TO DATE ON PREVENTIVE CARE 130 00:06:25,013 --> 00:06:27,049 SUCH AS CANCER SCREENING. IN 131 00:06:27,049 --> 00:06:29,351 FACT, CONSEQUENCE OF ILL 132 00:06:29,351 --> 00:06:31,353 IMPROVED TRIAGED PRACTICES 133 00:06:31,353 --> 00:06:33,088 DURING THE COVID-19 PANDEMIC, 134 00:06:33,088 --> 00:06:34,289 THE DEPARTMENT OF HEALTH AND 135 00:06:34,289 --> 00:06:37,692 HUMAN SERVICES HAD TO ISSUE A 136 00:06:37,692 --> 00:06:40,429 BULLETIN AND I READ, REAFFIRMING 137 00:06:40,429 --> 00:06:41,596 THAT PERSONS WITH DISABILITIES 138 00:06:41,596 --> 00:06:43,932 SHOULD NOT BE DENIED MEDICAL 139 00:06:43,932 --> 00:06:47,402 CARE ON THE BASES OF STEREO 140 00:06:47,402 --> 00:06:49,704 TYPES, ASSESSMENTS OF QUALITY OF 141 00:06:49,704 --> 00:06:51,239 LIFE OR JUDGMENTS ABOUT A 142 00:06:51,239 --> 00:06:52,707 PERSON'S RELATIVE WORTH BASED ON 143 00:06:52,707 --> 00:06:58,046 THE PRESENCE OR ABSENCE OF 144 00:06:58,046 --> 00:06:59,748 DISABILITIES. BESIDES THE 145 00:06:59,748 --> 00:07:01,016 OBJECTIVES AND EXPECTATIONS OF 146 00:07:01,016 --> 00:07:05,120 THIS NOFO IS TO INVITE 147 00:07:05,120 --> 00:07:05,754 APPLICATIONS THAT CENTER THE 148 00:07:05,754 --> 00:07:08,957 SOCIAL MODEL OF DISABILITY, TO 149 00:07:08,957 --> 00:07:11,660 BETTER UNDERSTAND MECHANISMS BY 150 00:07:11,660 --> 00:07:14,229 WHICH ABLEISM INFLUENCES THE 151 00:07:14,229 --> 00:07:16,131 HEALTH OF PEOPLE WITH 152 00:07:16,131 --> 00:07:17,866 DISABILITIES. WE INVITE 153 00:07:17,866 --> 00:07:20,035 APPLICATION TO INTERVENE AT A 154 00:07:20,035 --> 00:07:21,436 COMMUNITY OR HEALTH SYSTEMS 155 00:07:21,436 --> 00:07:26,074 LEVEL TO MITIGATE ADVERSE HEALTH 156 00:07:26,074 --> 00:07:28,009 EFFECTS OF ABLEISM. STUDIES CAN 157 00:07:28,009 --> 00:07:29,644 BE OBSERVATIONAL SUCH THAT 158 00:07:29,644 --> 00:07:33,115 THEY'RE LOOKING AT IMPACTSES OF 159 00:07:33,115 --> 00:07:35,650 ABLEISM, IMPACT OF EXTANT OR 160 00:07:35,650 --> 00:07:38,987 EXISTING FACTORS, LOOKING AT 161 00:07:38,987 --> 00:07:41,623 POLICIES, AND IMPACT OF THOSE 162 00:07:41,623 --> 00:07:42,991 POLICIES AND LAWS AND THE HELD 163 00:07:42,991 --> 00:07:46,128 OF INDIVIDUALS, FAMILIES AND 164 00:07:46,128 --> 00:07:47,429 COMMUNITIES. STUDIES MAY 165 00:07:47,429 --> 00:07:50,098 INVOLVE DATA COLLECTIONS OR NEW 166 00:07:50,098 --> 00:07:52,901 DATA OR THEY MAY PROPOSE TO 167 00:07:52,901 --> 00:08:00,408 ANALYZE EXISTING DATA. STUDIES 168 00:08:00,408 --> 00:08:04,846 COULD INTERVENE AND STUDIES ARE 169 00:08:04,846 --> 00:08:06,548 PRIMARILY ADDRESS ABLEISM TO 170 00:08:06,548 --> 00:08:09,417 IMPROVE HEALTH OUTCOMES. 171 00:08:09,417 --> 00:08:11,386 STUDIES COULD ALSO HAVE ABLEISM 172 00:08:11,386 --> 00:08:15,757 AS ONE OF SEVERAL DETERMINANTS 173 00:08:15,757 --> 00:08:17,859 OF HEALTH AND SO WHAT THOSE 174 00:08:17,859 --> 00:08:21,296 STUDIES WOULD LOOK LIKE WOULD BE 175 00:08:21,296 --> 00:08:24,533 SUCH THAT THEY HAVE ABLEISM AS 176 00:08:24,533 --> 00:08:26,268 ONE OF THE OUTCOMES THAT THEY'RE 177 00:08:26,268 --> 00:08:28,670 LOOKING AT, NOT ONE OF THE 178 00:08:28,670 --> 00:08:30,071 OUTCOMES TO DETERMINE, BUT 179 00:08:30,071 --> 00:08:32,307 THEY'RE LOOKING AT, HOWEVER, 180 00:08:32,307 --> 00:08:34,843 THERE'S NO REQUIREMENT THAT THE 181 00:08:34,843 --> 00:08:36,545 SOLE DETERMINANT BE ABLEISM. IT 182 00:08:36,545 --> 00:08:40,549 CAN BE ONE OF SEVERAL 183 00:08:40,549 --> 00:08:41,283 DETERMIN 184 00:08:41,283 --> 00:08:45,487 DETERMINANTS. NEXT SLIDE, 185 00:08:45,487 --> 00:08:47,622 PLEASE. IF STUDIES WERE PUT IN 186 00:08:47,622 --> 00:08:50,492 A INTERVENTION SUCH THAT IT MUST 187 00:08:50,492 --> 00:08:52,127 DIRECTLY ADDRESS THE CAUSE OR 188 00:08:52,127 --> 00:08:54,162 MECHANISM OF ABLEISM, NOT HELP 189 00:08:54,162 --> 00:08:56,932 INDIVIDUALS OF POPULATIONS WITH 190 00:08:56,932 --> 00:08:59,834 DISABILITY COPE WITH ABLEISM. 191 00:08:59,834 --> 00:09:09,778 INVESTIGATORS WILL COLLABORATE 192 00:09:09,778 --> 00:09:10,412 WITH ORGANIZATIONS, AGENCIES OR 193 00:09:10,412 --> 00:09:11,079 PROGRAMS AND INTERVENTIONS WILL 194 00:09:11,079 --> 00:09:12,747 ENGAGE OTHER RELEVANT ACTORS. 195 00:09:12,747 --> 00:09:15,150 FOR EXAMPLE, IN A SCHOOL SYSTEM 196 00:09:15,150 --> 00:09:17,719 TEACHERS EXPECTED THAT TEACHERS 197 00:09:17,719 --> 00:09:21,089 ARE INVOLVED, OR ENGAGED IN 198 00:09:21,089 --> 00:09:22,424 WHATEVER SOLUTIONS THAT ARE 199 00:09:22,424 --> 00:09:23,525 BEING PROPOSED AND IN HEALTH 200 00:09:23,525 --> 00:09:25,427 CARE SYSTEMS, THERE'S THE 201 00:09:25,427 --> 00:09:26,795 EXPECTATION THAT CLINICIANS WILL 202 00:09:26,795 --> 00:09:29,264 BE ENGAGED AND SO ON. AND SO 203 00:09:29,264 --> 00:09:31,866 THESE ENGAGEMENTS SHOULD BE 204 00:09:31,866 --> 00:09:34,836 APPROPRIATE TO THE SETTING OF 205 00:09:34,836 --> 00:09:36,071 INTERVENTION AND AGAIN, THEY 206 00:09:36,071 --> 00:09:39,174 SHOULD AIM TO ENACT CHANGES TO 207 00:09:39,174 --> 00:09:41,042 COMBAT ABLEST PRACTICES AND 208 00:09:41,042 --> 00:09:42,410 POLICIES. INTERVENTION SHOULD 209 00:09:42,410 --> 00:09:43,878 NOT ONLY TARGET PEOPLE WITH 210 00:09:43,878 --> 00:09:47,649 DISABILITIES WHO ARE DIRECTLY 211 00:09:47,649 --> 00:09:49,017 EXPERIENCING ABLEISM. 212 00:09:49,017 --> 00:09:51,753 APPLICATIONS WILL INCLUDE A PLAN 213 00:09:51,753 --> 00:09:58,827 TO INCLUDE LIVED EXPERIENCES AS 214 00:09:58,827 --> 00:10:04,599 OTHER ATTACHMENT. NEXT SLIDE, 215 00:10:04,599 --> 00:10:08,703 PLEASE. SO NICHD SPECIFIC 216 00:10:08,703 --> 00:10:10,672 INTERESTS. NICHD IS INTERESTED 217 00:10:10,672 --> 00:10:12,407 IN PROJECTS THAT FOCUS ON 218 00:10:12,407 --> 00:10:15,043 ABLEISM WRODLY INCLUDING 219 00:10:15,043 --> 00:10:16,845 DEVELOPING AND VALIDATING 220 00:10:16,845 --> 00:10:18,780 MEASURES OF ABLEISM ACROSS AGES 221 00:10:18,780 --> 00:10:22,417 AND THIS IS REALLY IMPORTANT. 222 00:10:22,417 --> 00:10:25,920 SO IT'S IMPORTANT THAT FOLKS ARE 223 00:10:25,920 --> 00:10:27,188 NOT THROWN BY THE WORD CHILD IN 224 00:10:27,188 --> 00:10:30,358 THE NAME OF OUR INSTITUTE. 225 00:10:30,358 --> 00:10:31,960 WE'RE INTERESTED IN APPLICATIONS 226 00:10:31,960 --> 00:10:34,596 ACROSS AGES, ACROSS LEVELS OF 227 00:10:34,596 --> 00:10:35,497 FUNCTIONING, ACROSS DIFFERENT 228 00:10:35,497 --> 00:10:42,203 TYPES OF DISABILITIES. 229 00:10:42,203 --> 00:10:43,505 INTERVENTIONS TO COMBAT ABLEISM 230 00:10:43,505 --> 00:10:45,240 AT A HEALTH SYSTEMS LEVEL 231 00:10:45,240 --> 00:10:46,708 INCLUDING THOSE THAT REDUCE 232 00:10:46,708 --> 00:10:48,743 DIAGNOSTIC OVERSHADOWING. 233 00:10:48,743 --> 00:10:50,879 INTERVENTION OF APPLICATIONS TO 234 00:10:50,879 --> 00:10:52,914 HELP UNDERSTAND THE EFFECT OF 235 00:10:52,914 --> 00:10:54,449 ABLEISM AND SELF-DETERMINATION 236 00:10:54,449 --> 00:10:57,752 RELATED TO REPRODUCTION AND 237 00:10:57,752 --> 00:10:58,853 REPRODUCTIVE HEALTH. AND 238 00:10:58,853 --> 00:11:00,422 INTERVENTIONS TO REDUCE EFFECTS 239 00:11:00,422 --> 00:11:04,426 OF ABLEISM ON ACCESS AND 240 00:11:04,426 --> 00:11:07,295 REFERRAL TO ROUTINE PREVENTATIVE 241 00:11:07,295 --> 00:11:11,066 CARE. TECHNOLOGY TO INCREASE 242 00:11:11,066 --> 00:11:11,599 ACCESSIBILITY OF MEDICAL 243 00:11:11,599 --> 00:11:12,167 EQUIPMENT, ESPECIALLY FOR 244 00:11:12,167 --> 00:11:15,103 IMAGING TECHNOLOGY. EXAMPLES OF 245 00:11:15,103 --> 00:11:17,038 NONRESPONSIVE APPLICATIONS WOULD 246 00:11:17,038 --> 00:11:21,009 BE APPLICATIONS THAT FOCUS ON 247 00:11:21,009 --> 00:11:22,177 REDUCING DISABILITY, 248 00:11:22,177 --> 00:11:23,445 APPLICATIONS THAT ARE NOT 249 00:11:23,445 --> 00:11:25,513 CONNECTED TO HEALTH OUTCOMES, 250 00:11:25,513 --> 00:11:30,318 APPLICATIONS THAT FOCUS ON 251 00:11:30,318 --> 00:11:32,754 DOCUMENTING HEALTH DISPARITIES 252 00:11:32,754 --> 00:11:36,091 FOR PEOPLE DISANDS WITHOUT 253 00:11:36,091 --> 00:11:37,092 REFERENCING ABLEISM. AND 254 00:11:37,092 --> 00:11:39,094 PERSON'S EXPERIENCING ABLEISM 255 00:11:39,094 --> 00:11:42,630 AND COMPLETELY IGNORE THE SYSTEM 256 00:11:42,630 --> 00:11:44,566 WHERE ABLEISM IS BEING 257 00:11:44,566 --> 00:11:48,870 PERPETUATED. NEXT SLIDE, 258 00:11:48,870 --> 00:11:52,173 PLEASE. COMING FROM NEI COULD 259 00:11:52,173 --> 00:11:54,542 NOT BE HERE SO I WILL TOUCH ON 260 00:11:54,542 --> 00:11:56,044 THEIR SPECIFIC INTERESTS. 261 00:11:56,044 --> 00:11:57,112 THEY'RE INTERESTED IN 262 00:11:57,112 --> 00:11:58,079 APPLICATIONS, ADDRESSING 263 00:11:58,079 --> 00:12:00,715 RESEARCH GAPS AND OPPORTUNITIES 264 00:12:00,715 --> 00:12:02,117 TO UNDERSTAND AND OR MITIGATE 265 00:12:02,117 --> 00:12:04,652 THE HEALTH IMPACTSES OF ABLEISM 266 00:12:04,652 --> 00:12:08,523 ON PEOPLE WHO ARE BLIND ARE HAVE 267 00:12:08,523 --> 00:12:10,325 LOW VISION. NONRESPONSIVE 268 00:12:10,325 --> 00:12:13,194 APPLICATIONS TO NEI WOULD BE 269 00:12:13,194 --> 00:12:14,362 THOSE PROPOSING CLINICAL TRIALS 270 00:12:14,362 --> 00:12:20,201 THAT ARE GREATER THAN MINIMAL 271 00:12:20,201 --> 00:12:22,771 RISK. AND WE'VE LINKED WHAT 272 00:12:22,771 --> 00:12:24,539 CONSTITUTES APPLICATION GREATER 273 00:12:24,539 --> 00:12:28,209 THAN MINIMAL RISK FOR NEI'S 274 00:12:28,209 --> 00:12:30,478 POLICY. NEXT SLIDE, PLEASE. 275 00:12:30,478 --> 00:12:34,749 I'LL TURN IT OVER TO MY 276 00:12:34,749 --> 00:12:36,251 COLLEAGUE, DR. BITMAN TO ADDRESS 277 00:12:36,251 --> 00:12:38,086 SPECIFIC INTERESTS. 278 00:12:38,086 --> 00:12:46,094 >> THANKS TROYEN. SO NIBIB IS 279 00:12:46,094 --> 00:12:47,996 PRIMARILY INTERESTED IN 280 00:12:47,996 --> 00:12:49,264 APPLICATIONS THAT REDESIGN 281 00:12:49,264 --> 00:12:50,665 MEDICAL TECHNOLOGIES. WE ARE 282 00:12:50,665 --> 00:12:52,634 VERY ENTHUSIASTIC ABOUT 283 00:12:52,634 --> 00:12:55,937 TECHNOLOGIES THAT INCORPORATE A 284 00:12:55,937 --> 00:12:58,039 UNIVERSAL DESIGN APPROACH AND 285 00:12:58,039 --> 00:13:00,442 AGAIN, IN LINE WITH THE OVERALL 286 00:13:00,442 --> 00:13:02,143 MISSION OF THIS FUNDING 287 00:13:02,143 --> 00:13:03,344 ANNOUNCEMENT, REDESIGN SHOULD 288 00:13:03,344 --> 00:13:05,380 IMPROVE ACCESSIBILITY AND EASE 289 00:13:05,380 --> 00:13:08,550 OF USE FOR ALL. WE HAVE SOME 290 00:13:08,550 --> 00:13:09,451 CONSTRAINTS ON CLINICAL TRIALS 291 00:13:09,451 --> 00:13:12,921 AND SO IF YOU ARE INTERESTED IN 292 00:13:12,921 --> 00:13:14,889 NIBIB AND PURSUING A CLINICAL 293 00:13:14,889 --> 00:13:16,224 TRIAL, DEFINITELY REACH OUT TO 294 00:13:16,224 --> 00:13:18,626 US. WE ONLY SUPPORT EARLY STAGE 295 00:13:18,626 --> 00:13:20,662 CLINICAL TRIAL APPLICATIONS SO 296 00:13:20,662 --> 00:13:24,899 THESE ARE MORE FEASIBILITY IN 297 00:13:24,899 --> 00:13:27,101 PHASE ONE IN HUMAN STUDIES AND 298 00:13:27,101 --> 00:13:28,837 WE ONLY SUPPORT MECHANISTIC 299 00:13:28,837 --> 00:13:31,206 TRIALS IF THE FOCUS IS ON 300 00:13:31,206 --> 00:13:34,676 TECHNOLOGY DEVELOPMENT ITSELF. 301 00:13:34,676 --> 00:13:35,577 THANK YOU. 302 00:13:35,577 --> 00:13:41,216 >> THANKS. NEXT SLIDE, PLEASE. 303 00:13:41,216 --> 00:13:42,484 AGAIN, COLLEAGUES FROM NATIONAL 304 00:13:42,484 --> 00:13:43,852 CANCER INSTITUTE COULD NOT BE 305 00:13:43,852 --> 00:13:46,287 HERE SO I WILL TOUCH ON THEIR 306 00:13:46,287 --> 00:13:47,956 SPECIFIC INTEREST. NCI IS 307 00:13:47,956 --> 00:13:50,091 INTERESTED IN APPLICATIONS THAT 308 00:13:50,091 --> 00:13:52,527 ADDRESS HOW ABLEISM PREVENTS 309 00:13:52,527 --> 00:13:54,629 BARRIERS TO TIMELY CANCER 310 00:13:54,629 --> 00:13:58,132 PREVENTIVE CARE, SCREENING, 311 00:13:58,132 --> 00:14:00,134 DIAGNOSIS, TREATMENT AND 312 00:14:00,134 --> 00:14:02,403 FOLLOWUP AND IMPEDES ACCESS TO 313 00:14:02,403 --> 00:14:04,806 AND DELIVERY OF CANCER CARE THAT 314 00:14:04,806 --> 00:14:06,241 CONTRIBUTES TO HEALTH 315 00:14:06,241 --> 00:14:11,513 DISPARITIES FOR PERSONS WITH 316 00:14:11,513 --> 00:14:15,283 PHYSICAL MOBILITY AND/OR SENSORY 317 00:14:15,283 --> 00:14:16,551 DISABILITIES. UNDERSTANDING HOW 318 00:14:16,551 --> 00:14:17,785 THE INTERSECTION WITH ABLEISM 319 00:14:17,785 --> 00:14:19,721 WITH OTHER FORMS OF OPPRESSION 320 00:14:19,721 --> 00:14:21,990 PLAY OUT AND AFFECT THE QUALITY 321 00:14:21,990 --> 00:14:25,860 OF CANCER PREVENTATIVE CARE, 322 00:14:25,860 --> 00:14:26,995 DIAGNOSIS, TREATMENT AND 323 00:14:26,995 --> 00:14:28,263 FOLLOWUP CARE. AND CONTRIBUTES 324 00:14:28,263 --> 00:14:29,931 TO CANCER HEALTH DISPARITIES FOR 325 00:14:29,931 --> 00:14:33,868 PEOPLE WITH DISABILITIES. 326 00:14:33,868 --> 00:14:35,169 THEY'RE ALSO INTERESTED IN 327 00:14:35,169 --> 00:14:37,138 DEVELOPING MODELS OF HEALTH CARE 328 00:14:37,138 --> 00:14:38,373 DELIVERY THAT SUPPORT PEOPLE 329 00:14:38,373 --> 00:14:40,341 WITH DISABILITIES RECEIVING 330 00:14:40,341 --> 00:14:42,710 GUIDELINE CONCORDANT CANCER 331 00:14:42,710 --> 00:14:47,815 CARE. NEXT SLIDE, PLEASE. I'LL 332 00:14:47,815 --> 00:14:53,988 TURN IT OVER TO DR. ROBBINS. 333 00:14:53,988 --> 00:15:00,061 >> NEXT SLIDE, PLEASE. SO NICHD 334 00:15:00,061 --> 00:15:02,030 SIEVENT TIFK REVIEW BRANCH WILL 335 00:15:02,030 --> 00:15:04,365 COORDINATE THE REVIEW OF THESE 336 00:15:04,365 --> 00:15:04,999 APPLICATIONS SUBMITTED UNDER 337 00:15:04,999 --> 00:15:07,335 THIS RFA. APPLICATIONS BEEN 338 00:15:07,335 --> 00:15:10,038 ASSIGNED TO A SPECIAL EMPHASIS 339 00:15:10,038 --> 00:15:11,406 PANEL REVIEW MEETING WHICH MEANS 340 00:15:11,406 --> 00:15:15,510 THAT THE ROSTER WILL BECOME A 341 00:15:15,510 --> 00:15:20,315 PART OF AN AGGREGATE ROSTER. 342 00:15:20,315 --> 00:15:22,584 AND THE ADMINISTRATIVE REVIEW 343 00:15:22,584 --> 00:15:28,222 WILL BE BASED ON THE 344 00:15:28,222 --> 00:15:28,856 RFA-HD-24-007 REQUIREMENTS AND 345 00:15:28,856 --> 00:15:31,793 THERE IS A LINK FOR THAT RFA 346 00:15:31,793 --> 00:15:37,031 ALONG WITH A LINK FOR THE NIH 347 00:15:37,031 --> 00:15:37,565 PEER REVIEW POLICIES AND 348 00:15:37,565 --> 00:15:40,802 PROCEDURES. WE WILL 349 00:15:40,802 --> 00:15:42,236 COLLECTIVELY -- WE WILL RECRUIT 350 00:15:42,236 --> 00:15:44,372 SCIENTIFIC EXPERTISE BASED ON 351 00:15:44,372 --> 00:15:46,307 THE CONTENTS OF THE APPLICATIONS 352 00:15:46,307 --> 00:15:47,241 THAT HAVE BEEN RECEIVED. AT 353 00:15:47,241 --> 00:15:49,010 LEAST THREE REVIEWERS WILL BE 354 00:15:49,010 --> 00:15:50,278 ASSIGNED TO EACH APPLICATION AND 355 00:15:50,278 --> 00:15:52,313 AS MANY OF YOU ARE PROBABLY WELL 356 00:15:52,313 --> 00:15:53,781 AWARE, PLEASE DO NOT CONTACT ANY 357 00:15:53,781 --> 00:15:58,419 MEMBERS OF THE REVIEW PANEL AND 358 00:15:58,419 --> 00:16:01,255 POST SUBMISSION MATERIALS PER 359 00:16:01,255 --> 00:16:09,263 NIH POLICY AND OT-OD-19-083. 360 00:16:09,263 --> 00:16:11,065 LINKS FOR BOTH OF THESE WILL BE 361 00:16:11,065 --> 00:16:13,134 MADE AVAILABLE. YOU WILL HAVE 362 00:16:13,134 --> 00:16:16,371 30 DAYS PRIOR TO THE ACTUALLY 363 00:16:16,371 --> 00:16:19,574 VIEW MEETING DATE TO SUBMIT ANY 364 00:16:19,574 --> 00:16:22,710 POST SUBMISSION MATERIALS. 365 00:16:22,710 --> 00:16:26,681 AGAIN, REVIEWERS WILL 366 00:16:26,681 --> 00:16:29,350 CONSIDER THE CRITERIA DESCRIBED 367 00:16:29,350 --> 00:16:35,857 IN THE RFA-HD-24-007 TO 368 00:16:35,857 --> 00:16:37,558 DETERMINE THE MERIT. WE 369 00:16:37,558 --> 00:16:39,394 ENCOURAGE YOU TO CAREFULLY READ 370 00:16:39,394 --> 00:16:40,695 SECTION 5 AND SPECIFICALLY AGAIN 371 00:16:40,695 --> 00:16:42,930 LOOK AT THE QUESTIONS THAT 372 00:16:42,930 --> 00:16:43,631 REVIEWERS WILL BE ASKED TO 373 00:16:43,631 --> 00:16:46,234 CONSIDER WHEN THEY REVIEW THESE 374 00:16:46,234 --> 00:16:49,337 APPLICATIONS. IF PROPOSING A 375 00:16:49,337 --> 00:16:50,271 CLINICAL TRIAL ADDRESS THE 376 00:16:50,271 --> 00:16:52,373 SPECIFIC QUESTIONS RELATED TO 377 00:16:52,373 --> 00:16:54,776 CLINICAL TRIALS. REVIEWERS WILL 378 00:16:54,776 --> 00:16:56,678 PROVIDE AN OVERALL IMPACT SCORE 379 00:16:56,678 --> 00:16:58,079 REFLECTING THEIR ASSESSMENT OF 380 00:16:58,079 --> 00:17:02,450 THE LIKELIHOOD OF THE PROJECT, 381 00:17:02,450 --> 00:17:04,485 WHETHER THE PROJECT WILL EXERT A 382 00:17:04,485 --> 00:17:06,254 SUSTAINED POWERFUL INFLUENCE ON 383 00:17:06,254 --> 00:17:07,989 THE RESEARCH FIELD AND THEY WILL 384 00:17:07,989 --> 00:17:11,092 ALSO GIVE INDIVIDUAL CRITERIA 385 00:17:11,092 --> 00:17:13,861 SCORES FOR SIGNIFICANCE, 386 00:17:13,861 --> 00:17:14,429 INVESTIGATOR, INNOVATION 387 00:17:14,429 --> 00:17:17,799 APPROACH AND ENVIRONMENT. NEXT 388 00:17:17,799 --> 00:17:22,704 SLIDE, PLEASE. SPECIFIC TO THIS 389 00:17:22,704 --> 00:17:24,372 RFA, THERE ARE SOME KEY ITEMS 390 00:17:24,372 --> 00:17:26,040 THAT YOU SHOULD CONSIDER WHEN 391 00:17:26,040 --> 00:17:27,608 SUBMITTING YOUR APPLICATION. 392 00:17:27,608 --> 00:17:29,343 DOES THE APPLICATION INCORPORATE 393 00:17:29,343 --> 00:17:30,978 PEOPLE WITH LIVED EXPERIENCE IN 394 00:17:30,978 --> 00:17:33,548 A WAY THAT INFORMS THE 395 00:17:33,548 --> 00:17:36,184 SCIENTIFIC AIMS OF THE 396 00:17:36,184 --> 00:17:37,952 APPLICATION AND INCREASES OR 397 00:17:37,952 --> 00:17:40,188 VALIDATES THE POTENTIAL IMPACT 398 00:17:40,188 --> 00:17:43,825 OF THE APPLICATION AND YOU 399 00:17:43,825 --> 00:17:45,259 SHOULD ALSO CONSIDER IF AN 400 00:17:45,259 --> 00:17:47,428 INTERVENTION IS PROPOSED, DOES 401 00:17:47,428 --> 00:17:48,629 THE PROPOSED INTERVENTION HAVE 402 00:17:48,629 --> 00:17:51,466 THE POTENTIAL TO BE WILDLY 403 00:17:51,466 --> 00:17:53,568 ADOPTED AND THERE BY IMPROVE THE 404 00:17:53,568 --> 00:17:56,137 HEALTH OF A BROAD SPECTRUM OF 405 00:17:56,137 --> 00:17:57,371 PEOPLE WITH DISABILITIES. 406 00:17:57,371 --> 00:18:00,441 PLEASE REFER TO THE ADDITIONAL 407 00:18:00,441 --> 00:18:01,676 REVIEW CRITERIA THAT ARE LISTED 408 00:18:01,676 --> 00:18:07,215 IN THE RFA. AS MANY OF YOU ARE 409 00:18:07,215 --> 00:18:10,084 WELL AWARE NIH UTILIZES A 410 00:18:10,084 --> 00:18:12,653 NINE-POINT RATING SCALE. ONE TO 411 00:18:12,653 --> 00:18:15,089 NINE, ONE BEING EXCEPTIONAL. 412 00:18:15,089 --> 00:18:16,791 NINE BEING POOR FOR ALL -- AND 413 00:18:16,791 --> 00:18:18,960 WE WILL BE USING THIS SCALE FOR 414 00:18:18,960 --> 00:18:20,862 ALL OF THESE APPLICATIONS. WE 415 00:18:20,862 --> 00:18:23,297 HAVE A LINK THAT GIVES YOU THE 416 00:18:23,297 --> 00:18:25,533 SCALE ALONG WITH THE OVERALL 417 00:18:25,533 --> 00:18:27,335 IMPACT SCORES AND AGAIN, EACH 418 00:18:27,335 --> 00:18:29,003 ASSIGNED REVIEWER WILL GIVE A 419 00:18:29,003 --> 00:18:32,106 SCORE FOR EACH OF THE CRITERIA 420 00:18:32,106 --> 00:18:35,343 OF SIGNIFICANCE, INVESTIGATOR 421 00:18:35,343 --> 00:18:35,843 INNOVATION APPROACH AND 422 00:18:35,843 --> 00:18:37,845 ENVIRONMENT. IN ADDITION TO A 423 00:18:37,845 --> 00:18:40,081 PRELIMINARY OVERALL IMPACT 424 00:18:40,081 --> 00:18:41,616 SCORE. THE PRELIMINARY SCORES 425 00:18:41,616 --> 00:18:44,385 WILL ACTUALLY DETERMINE WHICH 426 00:18:44,385 --> 00:18:45,319 APPLICATIONS WILL BE DISCUSSED 427 00:18:45,319 --> 00:18:47,655 AT THE REVIEW MEETING ALL OF THE 428 00:18:47,655 --> 00:18:48,623 REVIEWERS THAT ARE NOT IN 429 00:18:48,623 --> 00:18:50,525 CONFLICT WITH AN APPLICATION 430 00:18:50,525 --> 00:18:55,062 WILL PROVIDE A FINAL IMPACT 431 00:18:55,062 --> 00:18:58,032 SCORE AND YOUR FINAL, FINAL 432 00:18:58,032 --> 00:18:58,733 IMPACT SCORE WILL THEN BE BASED 433 00:18:58,733 --> 00:19:01,102 ON THE AVERAGE OF ALL THE VOTING 434 00:19:01,102 --> 00:19:02,970 REVIEWERS MULTIPLIED BY TEN. 435 00:19:02,970 --> 00:19:05,640 THE FINAL IMPACT STORE WILL BE 436 00:19:05,640 --> 00:19:07,608 RELEASED WITHIN THREE BUSINESS 437 00:19:07,608 --> 00:19:09,110 DAYS AFTER THE REVIEW MEETING 438 00:19:09,110 --> 00:19:12,680 HAS CONCLUDED AND YOUR SUMMARY 439 00:19:12,680 --> 00:19:14,382 STATEMENT CAN BE FOUND IN YOUR 440 00:19:14,382 --> 00:19:15,750 COMMENTS ACCOUNT. TYPICALLY 441 00:19:15,750 --> 00:19:17,251 IT'S WITHIN 30 DAYS. EACH 442 00:19:17,251 --> 00:19:19,420 INSTITUTE DOES IT A LITTLE BIT 443 00:19:19,420 --> 00:19:21,556 DIFFERENT THAN CSR SO IT COULD 444 00:19:21,556 --> 00:19:24,192 BE ANYWHERE BETWEEN 4 TO 6 445 00:19:24,192 --> 00:19:25,626 WEEKS. NOTE THAT IMPACT SCORES 446 00:19:25,626 --> 00:19:27,161 ARE NOT PROVIDED FOR 447 00:19:27,161 --> 00:19:28,396 APPLICATIONS THAT ARE NOT 448 00:19:28,396 --> 00:19:31,065 DISCUSSED AT THE REVIEW MEETING. 449 00:19:31,065 --> 00:19:33,467 NEXT SLIDE, PLEASE. WE'VE 450 00:19:33,467 --> 00:19:35,136 PROVIDED YOU WITH SOME 451 00:19:35,136 --> 00:19:38,673 ADDITIONAL RESOURCES RELATED TO 452 00:19:38,673 --> 00:19:41,375 PEER REVIEW AND LINKS SO THE 453 00:19:41,375 --> 00:19:42,476 CENTER FOR SCIENTIFIC REVIEW HAS 454 00:19:42,476 --> 00:19:45,112 A SERIES OF WEBINARS AND VIDEOS 455 00:19:45,112 --> 00:19:47,548 TO PROVIDE INSIGHT INTO THE NIH 456 00:19:47,548 --> 00:19:51,652 GRANT APPLICATION REVIEW. WE 457 00:19:51,652 --> 00:19:54,222 ALSO LISTED NICHD SCIENTIFIC 458 00:19:54,222 --> 00:19:55,857 REVIEW BRANCH AND RESOURCES FOR 459 00:19:55,857 --> 00:19:57,992 USING ERA COMMONS AS WELL AS A 460 00:19:57,992 --> 00:19:59,193 LINK FOR SUBMISSION -- ANY 461 00:19:59,193 --> 00:20:01,195 PROBLEMS WITH THE SUBMISSION 462 00:20:01,195 --> 00:20:10,705 PROCESS AND AS ALWAYS, REKWER -- 463 00:20:10,705 --> 00:20:12,907 REFER TO THE SERVICE DESK WHEN 464 00:20:12,907 --> 00:20:14,442 SUBMITTING YOUR APPLICATIONS. 465 00:20:14,442 --> 00:20:17,445 AND I BELIEVE THAT IS IT. 466 00:20:17,445 --> 00:20:23,818 >> THANKS SO MUCH. NEXT SLIDE, 467 00:20:23,818 --> 00:20:29,457 PLEASE. KEY DATES. SO THE RFA 468 00:20:29,457 --> 00:20:32,026 WAS ORIGINALLY POSTED 469 00:20:32,026 --> 00:20:33,594 AUGUST 14TH, 2023. LETTERS OF 470 00:20:33,594 --> 00:20:36,731 INTENT WERE DUE ON OCTOBER 30TH. 471 00:20:36,731 --> 00:20:38,032 HOWEVER, WE'VE BEEN FAIRLY 472 00:20:38,032 --> 00:20:39,967 FLEXIBLE ON THOSE AND I WANT TO 473 00:20:39,967 --> 00:20:43,571 NOTE THAT LETTERS OF INTENT ARE 474 00:20:43,571 --> 00:20:47,508 NOT REQUIRED. THEY'RE JUST -- 475 00:20:47,508 --> 00:20:49,810 THEY HELP US PLAN IN TERMS OF 476 00:20:49,810 --> 00:20:52,647 PREPARING FOR THE APPLICATIONS 477 00:20:52,647 --> 00:20:54,582 THAT WILL COME IN RECRUITING 478 00:20:54,582 --> 00:20:56,550 REVIEWERS AND HOW MANY TO REVIEW 479 00:20:56,550 --> 00:20:59,720 AND SO ON. SO IT'S NOT A 480 00:20:59,720 --> 00:21:01,923 REQUIREMENT AND SO IF YOU 481 00:21:01,923 --> 00:21:06,627 HAVEN'T SUBMITTED ONE, THERE ARE 482 00:21:06,627 --> 00:21:09,130 NO PENALTY OR CONSEQUENCES, 483 00:21:09,130 --> 00:21:10,498 ADVERSE CONSEQUENCES FOR NOT 484 00:21:10,498 --> 00:21:13,234 HAVING SUBMITTED A LETTER OF 485 00:21:13,234 --> 00:21:16,203 INTENT. THE APPLICATION DUE 486 00:21:16,203 --> 00:21:21,108 DATE IS NOVEMBER 29TH. THE 487 00:21:21,108 --> 00:21:21,742 SCIENT 488 00:21:21,742 --> 00:21:23,911 SCIENT 489 00:21:23,911 --> 00:21:31,118 SCIENTIFIC MERIT REVIEW DATE IS 490 00:21:31,118 --> 00:21:32,386 MARCH 2024. NEXT SLIDE. 491 00:21:32,386 --> 00:21:38,259 PLEASE. AND THAT CONCLUDES THE 492 00:21:38,259 --> 00:21:40,127 PRESENTATION. SO WE'LL NOW 493 00:21:40,127 --> 00:21:41,462 LEAVE THE FLOOR OPEN. IT'S 494 00:21:41,462 --> 00:21:42,830 GREAT THAT WE HAVE A LOT OF TIME 495 00:21:42,830 --> 00:21:45,366 TO ENTERTAIN QUESTIONS SO PLEASE 496 00:21:45,366 --> 00:21:51,272 FEEL FREE TO POSE YOUR 497 00:21:51,272 --> 00:21:53,507 QUESTIONS. AND I'LL START. SO 498 00:21:53,507 --> 00:21:55,977 THE FIRST QUESTION YOU HAVE, IF 499 00:21:55,977 --> 00:21:58,579 THE PANELISTS DON'T MIND COMING 500 00:21:58,579 --> 00:22:00,348 OFF MUTE TO ANSWER THE QUESTIONS 501 00:22:00,348 --> 00:22:02,817 LIVE, THAT WOULD BE WONDERFUL. 502 00:22:02,817 --> 00:22:04,418 ALTHOUGH THE FOCUS IS ON 503 00:22:04,418 --> 00:22:06,454 PHYSICAL DISABILITIES, WOULD IT 504 00:22:06,454 --> 00:22:07,922 BE APPROPRIATE TO ADDRESS 505 00:22:07,922 --> 00:22:10,424 ABLEISM IN THE CONTEXT OF 506 00:22:10,424 --> 00:22:16,097 COGNITIVE AND/OR BEHAVIORAL 507 00:22:16,097 --> 00:22:16,464 IMPAIRMENTS. 508 00:22:16,464 --> 00:22:17,531 >> CAN I HOP IN HERE? 509 00:22:17,531 --> 00:22:20,401 >> ABSOLUTELY. 510 00:22:20,401 --> 00:22:21,836 >> AND CAN WE TAKE DOWN THE 511 00:22:21,836 --> 00:22:22,403 SLIDE SO PEOPLE CAN SEE US 512 00:22:22,403 --> 00:22:32,546 BETTER? HI, EVERYONE. I'M 513 00:22:32,546 --> 00:22:34,415 LOOKING AT THE WRONG CAMERA. 514 00:22:34,415 --> 00:22:40,121 HI, I'M TERESA CRUZ. I'M A 515 00:22:40,121 --> 00:22:43,424 MIDDLE AGED WHITE WOMAN WITH 516 00:22:43,424 --> 00:22:44,125 SHOULDER LENGTH BROWN HAIR AND 517 00:22:44,125 --> 00:22:46,060 BLUE EYES. I'VE GOT A GRAY 518 00:22:46,060 --> 00:22:48,129 JACKET ON TODAY WITH A PURPLE 519 00:22:48,129 --> 00:22:51,599 FLOWERY TOP AND MY BACKGROUND IS 520 00:22:51,599 --> 00:22:54,402 THE BLUE ZOOM BACKGROUND FOR 521 00:22:54,402 --> 00:22:57,038 NICHD. I JUST WANTED TO SAY I'M 522 00:22:57,038 --> 00:22:58,839 SO THANKFUL FOR TOYIN AND THE 523 00:22:58,839 --> 00:23:01,709 REST OF THE TEAM FOR PUTTING 524 00:23:01,709 --> 00:23:03,344 TOGETHER THIS WEBINAR AND FOR 525 00:23:03,344 --> 00:23:06,580 ALL OF YOU TO SHOW UP ON SUCH 526 00:23:06,580 --> 00:23:08,315 SHORT NOTICE AND I'M JUST BLOWN 527 00:23:08,315 --> 00:23:09,817 AWAY BY THE RESPONSE TO THIS AND 528 00:23:09,817 --> 00:23:15,056 HOW MANY PEOPLE ARE HERE. SO 529 00:23:15,056 --> 00:23:16,357 THANK YOU. SO I WOULD SAY THAT 530 00:23:16,357 --> 00:23:20,394 THERE IS A LINE IN THE RFA THAT 531 00:23:20,394 --> 00:23:23,364 SAYS NCMRR'S MISSION IS AROUND 532 00:23:23,364 --> 00:23:26,667 PHYSICAL DISABILITY BUT THAT IS 533 00:23:26,667 --> 00:23:29,170 NOT TRUE FOR ALL OF THE ICE 534 00:23:29,170 --> 00:23:33,240 INSTITUTES AND CENTERS WHO ARE 535 00:23:33,240 --> 00:23:34,675 PARTICIPATING. OF COURSE THE 536 00:23:34,675 --> 00:23:36,077 EYE INSTITUTE HAS INTEREST IN 537 00:23:36,077 --> 00:23:38,446 SENSORY DISABILITIES SO I -- WE 538 00:23:38,446 --> 00:23:40,781 ARE TAKING DISABILITY IN A 539 00:23:40,781 --> 00:23:46,187 BROADER CONTEXT. SO I WOULDN'T 540 00:23:46,187 --> 00:23:51,792 FOCUS TOO DEEPLY ON THAT. OKAY. 541 00:23:51,792 --> 00:23:55,896 I SEE A QUESTION FROM JAY 542 00:23:55,896 --> 00:23:57,164 KENNEDY. HEY, JAY. WHAT 543 00:23:57,164 --> 00:24:00,000 HAPPENS IF THE GOVERNMENT SHUTS 544 00:24:00,000 --> 00:24:03,871 DOWN? SO OFFICIALLY WE DON'T 545 00:24:03,871 --> 00:24:09,543 TALK ABOUT BRUNO. THAT'S OUR 546 00:24:09,543 --> 00:24:11,212 POLICY. WE WILL HAVE GUIDANCE 547 00:24:11,212 --> 00:24:12,346 IF THAT HAPPENS. OF COURSE WE 548 00:24:12,346 --> 00:24:13,747 ARE NOT PLANNING FOR THAT TO 549 00:24:13,747 --> 00:24:15,983 HAPPEN AND WE, YOU KNOW, EXPECT 550 00:24:15,983 --> 00:24:21,722 TO GET FUNDING AND TO REMAIN 551 00:24:21,722 --> 00:24:22,756 OPEN. BUT THERE WILL BE 552 00:24:22,756 --> 00:24:26,627 GUIDANCE FROM NIH FOR ALL 553 00:24:26,627 --> 00:24:32,166 SUBMISSIONS IF THERE IS A 554 00:24:32,166 --> 00:24:34,101 SHUTDOWN. WANT ME TO KEEP 555 00:24:34,101 --> 00:24:35,836 GOING, TOYIN, GIVE YOU A BREAK? 556 00:24:35,836 --> 00:24:38,339 >> YEAH. PLEASE. GOR FOR IT. 557 00:24:38,339 --> 00:24:40,841 >> OKAY. AND IS THERE A PLAN TO 558 00:24:40,841 --> 00:24:44,845 REOPEN THIS NOFO AND ALLOW FOR 559 00:24:44,845 --> 00:24:46,514 RESUBMISSIONS? WE HAVE ONE DUE 560 00:24:46,514 --> 00:24:50,351 DATE RIGHT NOW. THERE IS NO 561 00:24:50,351 --> 00:24:53,120 PLAN FOR ALLOWING -- FOR A 562 00:24:53,120 --> 00:24:57,258 REISSUE OF THIS SPECIFIC NOFO. 563 00:24:57,258 --> 00:25:00,561 BUT YOU CAN USE PARENT 564 00:25:00,561 --> 00:25:04,031 ANNOUNCEMENTS FOR THE RO1 TO 565 00:25:04,031 --> 00:25:05,466 EITHER PUT IN A NEW SUBMISSION 566 00:25:05,466 --> 00:25:07,768 ON THIS TOPIC OR A RESUBMISSION 567 00:25:07,768 --> 00:25:11,505 WITHIN THE ALLOWABLE TIMEFRAME. 568 00:25:11,505 --> 00:25:17,411 AND THAT'S ALL I CAN SAY ON THAT 569 00:25:17,411 --> 00:25:19,480 RIGHT NOW. OKAY. THERE'S A 570 00:25:19,480 --> 00:25:20,948 QUESTION, COULD YOU REVIEW THE 571 00:25:20,948 --> 00:25:23,617 KEY ITEMS TO CONSIDER, PLEASE? 572 00:25:23,617 --> 00:25:27,855 SO I WOULD DIRECT YOU TO THE 573 00:25:27,855 --> 00:25:31,292 FIVE REVIEW CRITERIA THAT NIH 574 00:25:31,292 --> 00:25:35,729 HAVE. SIGNIFICANCE, INNOVATION, 575 00:25:35,729 --> 00:25:37,464 INVESTIGATOR, APPROACH AND 576 00:25:37,464 --> 00:25:41,936 ENVIRONMENT AS WELL AS THE 577 00:25:41,936 --> 00:25:44,405 ADDITIONAL PLAN FOR INCLUDING 578 00:25:44,405 --> 00:25:47,608 LIVED EXPERIENCE, SO SECTION 5 579 00:25:47,608 --> 00:25:49,910 OF THE NOFO GOES THROUGH THE 580 00:25:49,910 --> 00:25:52,279 QUESTIONS THAT THE REVIEWERS ARE 581 00:25:52,279 --> 00:25:56,383 GOING TO BE ADDRESSING IN THAT 582 00:25:56,383 --> 00:26:06,894 REVIEW. THERE IS A QUESTION 583 00:26:07,795 --> 00:26:12,266 THAT SAYS IT LOOKS LIKE THE 584 00:26:12,266 --> 00:26:13,901 DATES GO THROUGH 2026. I THINK 585 00:26:13,901 --> 00:26:14,768 WE'RE LOOKING AT DIFFERENT 586 00:26:14,768 --> 00:26:19,006 THINGS. OURS IS A ONE-TIME DUE 587 00:26:19,006 --> 00:26:21,742 DATE, NOVEMBER 29TH, 2023. AND 588 00:26:21,742 --> 00:26:24,845 THEN IT EXPIRES THE NEXT DAY. 589 00:26:24,845 --> 00:26:27,147 I'M NOT QUITE SURE THAT WE'RE 590 00:26:27,147 --> 00:26:28,549 LOOKING AT THE SAME FUNDING 591 00:26:28,549 --> 00:26:38,959 OPPORTUNITY. WE HAVE A 592 00:26:39,526 --> 00:26:41,262 QUESTION, DOES EXPLORING RACIAL 593 00:26:41,262 --> 00:26:43,130 DISPARITY AMONG PERSONS WITH 594 00:26:43,130 --> 00:26:51,639 DISABILITY AND ACCESS TO CARE 595 00:26:51,639 --> 00:26:53,807 CONSIDER -- SORRY. WILL 596 00:26:53,807 --> 00:26:56,777 EXPLORING RACIAL DISPARITY AMONG 597 00:26:56,777 --> 00:26:58,545 PERSONS WITH DISABILITY AND 598 00:26:58,545 --> 00:27:00,547 ACCESS TO CARE WILL CONSIDER 599 00:27:00,547 --> 00:27:02,650 ABLEISM ASPECT OF THIS RFA? IS 600 00:27:02,650 --> 00:27:05,052 THERE ANY TEMPLATE FOR A LIVED 601 00:27:05,052 --> 00:27:06,887 EXPERIENCE? SO I'LL ANSWER THE 602 00:27:06,887 --> 00:27:08,889 SECOND PART. NO, WE DON'T HAVE 603 00:27:08,889 --> 00:27:14,228 A TEMPLATE, BUT WE HAVE USED 604 00:27:14,228 --> 00:27:16,397 THIS LANGUAGE BEFORE IN OUR 605 00:27:16,397 --> 00:27:19,700 PHYSICAL ACTIVITY FOR WHEELCHAIR 606 00:27:19,700 --> 00:27:22,836 USERS, RFA A COUPLE OF YEARS AGO 607 00:27:22,836 --> 00:27:25,005 AS WELL AS DOD HAS SOME REALLY 608 00:27:25,005 --> 00:27:26,874 GOOD LANGUAGE ABOUT 609 00:27:26,874 --> 00:27:30,444 INCORPORATING PERSONS WITH LIVED 610 00:27:30,444 --> 00:27:31,545 EXPERIENCE. SO THE FIRST 611 00:27:31,545 --> 00:27:33,781 QUESTION ABOUT THE RACIAL 612 00:27:33,781 --> 00:27:35,582 DISPARITIES AND THE INTERSECTION 613 00:27:35,582 --> 00:27:37,951 WITH DISABILITY, SO I THINK 614 00:27:37,951 --> 00:27:39,787 WE'VE LAID OUT THAT YOU CAN BE 615 00:27:39,787 --> 00:27:42,056 LOOKING AT THAT INTERSECTION SO 616 00:27:42,056 --> 00:27:44,291 WE'RE -- WE UNDERSTAND THAT 617 00:27:44,291 --> 00:27:47,528 DISABILITIES IS ONE ASPECT OF A 618 00:27:47,528 --> 00:27:49,697 PERSON'S IDENTITY SO WE DON'T 619 00:27:49,697 --> 00:27:51,899 WANT TO EXCLUDE THE OTHERS. I 620 00:27:51,899 --> 00:27:57,671 WILL SAY THAT THERE IS A PROGRAM 621 00:27:57,671 --> 00:28:00,708 ANNOUNCEMENT THAT NINHD HAS PUT 622 00:28:00,708 --> 00:28:05,879 OUT THAT DOES HAVE MULTIPLE DUE 623 00:28:05,879 --> 00:28:07,114 DATES PER YEAR AND TOYIN, I 624 00:28:07,114 --> 00:28:08,582 DON'T KNOW IF YOU CAN GET THAT 625 00:28:08,582 --> 00:28:11,919 RFA -- OR THAT NOFO LIKE THAT IS 626 00:28:11,919 --> 00:28:17,324 SPECIFICALLY LOOKING AT THE 627 00:28:17,324 --> 00:28:19,626 INTERSECTION OF MULTIPLE 628 00:28:19,626 --> 00:28:20,928 MARGINALIZED IDENTITIES. SO 629 00:28:20,928 --> 00:28:22,129 THAT MIGHT BE ANOTHER 630 00:28:22,129 --> 00:28:31,805 OPPORTUNITY FOR YOU TO LOOK AT. 631 00:28:31,805 --> 00:28:34,541 OKAY. FOR NICHD WILL 632 00:28:34,541 --> 00:28:36,410 UTILIZATION OF PREVENTIVE CARE 633 00:28:36,410 --> 00:28:38,812 SERVICES AND SCREENINGS AND/OR 634 00:28:38,812 --> 00:28:39,513 HOSPITALIZATIONS AND EMERGENCY 635 00:28:39,513 --> 00:28:43,450 DEPARTMENT USAGES BE INCLUDED? 636 00:28:43,450 --> 00:28:50,791 THE REQUIREMENT TO ADDRESS 637 00:28:50,791 --> 00:28:51,225 PUB 638 00:28:51,225 --> 00:28:54,862 PUBLIC -- VERSUS OUTCOMES. I'M 639 00:28:54,862 --> 00:28:59,099 HAVING A LITTLE TROUBLE 640 00:28:59,099 --> 00:29:00,134 FOLLOWING THIS QUESTION. BUT 641 00:29:00,134 --> 00:29:03,470 YES, I WOULD SAY IF YOU ARE 642 00:29:03,470 --> 00:29:05,406 LOOKING AT THE USE OF PREVENTIVE 643 00:29:05,406 --> 00:29:09,109 CARE SERVICES AND SCREENINGS, BY 644 00:29:09,109 --> 00:29:11,311 PEOPLE WITH DISABILITIES, THEN 645 00:29:11,311 --> 00:29:13,280 YES, THAT WOULD FALL -- IN 646 00:29:13,280 --> 00:29:15,649 ADDRESSING IT WITH THE LENS OF 647 00:29:15,649 --> 00:29:21,855 ABLEISM, THEN THAT WOULD BE 648 00:29:21,855 --> 00:29:24,758 APPROPRIATE. THIS IS TO MY 649 00:29:24,758 --> 00:29:25,726 TEAM. CAN EVERYBODY SEE THE Q&A 650 00:29:25,726 --> 00:29:29,596 OR IS IT JUST WHAT I'M READING? 651 00:29:29,596 --> 00:29:33,901 CAN THE ATTENDEES SEE THE Q&A? 652 00:29:33,901 --> 00:29:35,469 >> UNFORTUNATELY THE ATTENDEES 653 00:29:35,469 --> 00:29:38,105 CANNOT SEE THE Q&A. ONLY THE 654 00:29:38,105 --> 00:29:39,807 PANELISTS CAN SEE THE Q&A. SO 655 00:29:39,807 --> 00:29:40,974 EVERYBODY KNOWS I AM READING 656 00:29:40,974 --> 00:29:43,777 THEM IN ORDER. I'M NOT SKIPPING 657 00:29:43,777 --> 00:29:45,179 ANY. SO I JUST BE PATIENT WITH 658 00:29:45,179 --> 00:29:48,715 ME. THERE'S A FEW MORE. OKAY. 659 00:29:48,715 --> 00:29:51,752 WILL THE PROGRAM DIRECTOR BE 660 00:29:51,752 --> 00:29:53,921 ABLE TO HELP US TO DETERMINE 661 00:29:53,921 --> 00:29:55,589 WHETHER AN IDEA MATCHES THIS 662 00:29:55,589 --> 00:29:58,292 FUNDING PROGRAM? YES, YES, YES. 663 00:29:58,292 --> 00:30:01,361 PLEASE, IF YOU'RE NOT SURE, 664 00:30:01,361 --> 00:30:03,297 PLEASE SEND YOUR ABSTRACT OR 665 00:30:03,297 --> 00:30:05,065 YOUR, YOU KNOW, SPECIFIC AIMS OR 666 00:30:05,065 --> 00:30:10,604 A COUPLE OF SENTENCES TO TOYIN. 667 00:30:10,604 --> 00:30:12,606 THERE ARE OTHER CONTACTS FOR THE 668 00:30:12,606 --> 00:30:17,478 OTHER ICS AS WELL LIKE WE HAVE 669 00:30:17,478 --> 00:30:19,513 MORIA ON, SO WE WOULD BE HAPPY 670 00:30:19,513 --> 00:30:21,415 TO TAKE A LOOK AND GIVE YOU 671 00:30:21,415 --> 00:30:23,484 FEEDBACK ABOUT WHETHER YOUR 672 00:30:23,484 --> 00:30:26,053 PROJECT IS APPROPRIATE FOR THIS 673 00:30:26,053 --> 00:30:27,955 PARTICULAR RFA AND IF IT'S NOT, 674 00:30:27,955 --> 00:30:29,857 TO DIRECT YOU TO OTHER 675 00:30:29,857 --> 00:30:33,894 OPPORTUNITIES. THAT WOULD BE A 676 00:30:33,894 --> 00:30:41,468 BETTER MATCH. SO PLEASE DO 677 00:30:41,468 --> 00:30:45,939 THAT. OKAY. SOMEONE IS 678 00:30:45,939 --> 00:30:48,375 INTERESTED IN EXPLORING -- OR 679 00:30:48,375 --> 00:30:49,610 DEVELOPING ABLEISM INSTRUMENTS 680 00:30:49,610 --> 00:30:51,011 FOR YOUTH. THE SLIDE AT THE 681 00:30:51,011 --> 00:30:52,813 BEGINNING SAYS ACROSS ALL AGES. 682 00:30:52,813 --> 00:30:54,948 WOULD A FOCUS ON YOUTH BE 683 00:30:54,948 --> 00:30:56,016 UNRESPONSIVE? NO. THAT -- 684 00:30:56,016 --> 00:30:57,417 ACROSS ALL AGES IS TO INDICATE 685 00:30:57,417 --> 00:30:59,419 THAT WE ARE NOT ONLY LOOKING AT 686 00:30:59,419 --> 00:31:04,324 CHILD HEALTH, SO IF YOU HAD A 687 00:31:04,324 --> 00:31:06,260 SPECIFIC CHILD OR ADOLESCENT OR 688 00:31:06,260 --> 00:31:11,365 ADULT OR OLDER ADULT OUTCOME OR 689 00:31:11,365 --> 00:31:16,370 POPULATION, ALL OF THOSE WOULD 690 00:31:16,370 --> 00:31:25,145 BE APPROPRIATE. CAN YOU 691 00:31:25,145 --> 00:31:27,548 DESCRIBE HOW YOU ARE EVALUATING 692 00:31:27,548 --> 00:31:30,050 THE INCORPORATION OF LIVED 693 00:31:30,050 --> 00:31:32,219 EXPERIENCE? SO WHEN YOU GO TO 694 00:31:32,219 --> 00:31:39,593 SECTION 5, THERE ARE SPECIFIC 695 00:31:39,593 --> 00:31:41,194 PARTS -- I DON'T REMEMBER WHICH 696 00:31:41,194 --> 00:31:43,397 CRITERIA OR IF IT'S -- IT'S ONLY 697 00:31:43,397 --> 00:31:44,164 UNDER ONE. 698 00:31:44,164 --> 00:31:44,831 >> SIGNIFICANCE. 699 00:31:44,831 --> 00:31:47,467 >> OKAY. SO IF YOU LOOK AT THE 700 00:31:47,467 --> 00:31:48,669 REVIEW CRITERIA, THE 701 00:31:48,669 --> 00:31:53,473 SIGNIFICANCE, THERE'S A COUPLE 702 00:31:53,473 --> 00:31:54,675 SENTENCES THAT ADDRESS -- OR 703 00:31:54,675 --> 00:31:58,912 QUEUE THE REVIEWER TO LOOK AND 704 00:31:58,912 --> 00:32:01,281 ASK QUESTIONS ABOUT THE LIVED 705 00:32:01,281 --> 00:32:04,418 EXPERIENCE, SO WE ARE 706 00:32:04,418 --> 00:32:05,652 INCORPORATING THAT INFORMATION 707 00:32:05,652 --> 00:32:06,753 INTO THE SIGNIFICANCE SCORE. 708 00:32:06,753 --> 00:32:11,258 THANK YOU, TOYIN. WILL WE 709 00:32:11,258 --> 00:32:13,827 RECEIVE ANY FEEDBACK FROM OUR 710 00:32:13,827 --> 00:32:18,665 LETTER OF INTENT? NO, GENERALLY 711 00:32:18,665 --> 00:32:21,268 NOT. IF SOMETHING IS CLEARLY 712 00:32:21,268 --> 00:32:24,371 NOT A GOOD MATCH, THE PROGRAM 713 00:32:24,371 --> 00:32:27,407 OFFICER WILL LET YOU KNOW THAT. 714 00:32:27,407 --> 00:32:31,278 BUT WE'RE NOT GOING TO GIVE 715 00:32:31,278 --> 00:32:32,746 SCIENTIFIC FEEDBACK ON THE IDEAS 716 00:32:32,746 --> 00:32:35,282 THAT ARE PUT FORWARD. WE WOULD 717 00:32:35,282 --> 00:32:38,285 ONLY SAY WHETHER IT WAS 718 00:32:38,285 --> 00:32:38,752 APPROPRIATE OR NOT. 719 00:32:38,752 --> 00:32:42,956 >> I WONDER IF THEY'RE ASKING -- 720 00:32:42,956 --> 00:32:49,096 SO IF -- IF YOU SENT A LETTER OF 721 00:32:49,096 --> 00:32:50,530 INTEREST AND NEVER SENT IN 722 00:32:50,530 --> 00:32:53,166 THE -- SO FOLKS HAVE SOME OF 723 00:32:53,166 --> 00:32:54,868 LOIS HAVE HEARD FROM ME WHERE I 724 00:32:54,868 --> 00:32:57,070 ACKNOWLEDGE RECEIPT. HOWEVER, 725 00:32:57,070 --> 00:33:01,508 IF YOU WANTED FEEDBACK ON 726 00:33:01,508 --> 00:33:02,609 ALIGNMENT BETWEEN YOUR SPECIFIC 727 00:33:02,609 --> 00:33:05,612 AIMS AND THE RFA, THAT'S A 728 00:33:05,612 --> 00:33:06,380 DIFFERENT CONVERSATION. SO 729 00:33:06,380 --> 00:33:10,751 PLEASE REACH OUT AND SEND YOUR 730 00:33:10,751 --> 00:33:12,386 AGENT AND THEN REQUEST A CALL 731 00:33:12,386 --> 00:33:17,791 AND I'LL BE MORE THAN HAPPY TO 732 00:33:17,791 --> 00:33:18,425 DO THAT. 733 00:33:18,425 --> 00:33:23,497 >> THANK YOU, TOYIN. THERE'S A 734 00:33:23,497 --> 00:33:24,931 QUESTION ABOUT WHETHER AN 735 00:33:24,931 --> 00:33:27,300 INTERVENTION CAN BE KIND OF 736 00:33:27,300 --> 00:33:28,902 PRETEST, POST TEST SURVEY OR 737 00:33:28,902 --> 00:33:31,038 DOES IT HAVE TO BE A RANDOMIZED 738 00:33:31,038 --> 00:33:34,741 CONTROL TRIAL GIVEN THAT THIS IS 739 00:33:34,741 --> 00:33:40,981 NIH. WE DO NOT PRESCRIBE THE 740 00:33:40,981 --> 00:33:43,684 TYPE OF APPROACH ANYONE HAS TO 741 00:33:43,684 --> 00:33:46,486 TAKE BUT IT SHOULD BE 742 00:33:46,486 --> 00:33:49,356 SCIENTIFICALLY RIGOROUS SO 743 00:33:49,356 --> 00:33:53,193 DEPENDING ON THE SITUATION, THE 744 00:33:53,193 --> 00:33:55,162 INTERVENTION, THE AMOUNT OF 745 00:33:55,162 --> 00:33:56,830 PRELIMINARY DATA, YOU KNOW, 746 00:33:56,830 --> 00:33:59,466 THERE ARE -- THERE ARE LOTS OF 747 00:33:59,466 --> 00:34:02,335 OPTIONS FOR STUDY DESIGN, SO I 748 00:34:02,335 --> 00:34:05,372 WOULD SAY WE DO NOT REQUIRE IT 749 00:34:05,372 --> 00:34:07,841 TO BE AN RTC. THAT MAY NOT BE 750 00:34:07,841 --> 00:34:09,276 APPROPRIATE IN SOME CASES. 751 00:34:09,276 --> 00:34:12,479 RIGHT? SO IT'S UP TO THE 752 00:34:12,479 --> 00:34:13,780 APPLICANT TO SELECT THE STUDY 753 00:34:13,780 --> 00:34:17,350 DESIGN THAT THEY THINK IS MOST 754 00:34:17,350 --> 00:34:18,118 APPROPRIATE TO ANSWER THEIR 755 00:34:18,118 --> 00:34:23,256 SPECIFIC SCIENTIFIC QUESTION AND 756 00:34:23,256 --> 00:34:31,965 THEN DEFEND THAT. OKAY. I 757 00:34:31,965 --> 00:34:32,933 THINK THAT WAS THE LAST QUESTION 758 00:34:32,933 --> 00:34:35,202 SO WE'RE GOING TO HANG OUT FOR 759 00:34:35,202 --> 00:34:36,369 ANOTHER TWO MINUTES. JUST 760 00:34:36,369 --> 00:34:37,704 KIDDING. THERE'S ANOTHER 761 00:34:37,704 --> 00:34:39,239 QUESTION. WILL THE SLIDES FROM 762 00:34:39,239 --> 00:34:42,209 TODAY BE SENT OUT OR MADE 763 00:34:42,209 --> 00:34:45,278 AVAILABLE? YES. SO THE -- ONCE 764 00:34:45,278 --> 00:34:47,013 WE HAVE THE RECORDING, EVERYONE 765 00:34:47,013 --> 00:34:48,281 WHO REGISTERED WILL GET A COPY 766 00:34:48,281 --> 00:34:49,783 OF THE SLIDES BECAUSE WE DID 767 00:34:49,783 --> 00:34:52,786 HAVE A LOT OF HOT LINKS IN THERE 768 00:34:52,786 --> 00:34:56,623 AS WELL AS A LINK TO THIS 769 00:34:56,623 --> 00:34:57,758 RECORDING. IS THAT RIGHT, 770 00:34:57,758 --> 00:34:58,325 TOYIN? 771 00:34:58,325 --> 00:34:58,725 >> THAT'S RIGHT. 772 00:34:58,725 --> 00:35:05,465 >> OKAY. GOOD. 773 00:35:05,465 --> 00:35:07,434 >> AND I WANTED TO ADDRESS THE 774 00:35:07,434 --> 00:35:10,771 OTHER QUESTION I RECEIVED VIA 775 00:35:10,771 --> 00:35:15,041 E-MAIL AND THE PI COLLABORATING 776 00:35:15,041 --> 00:35:18,445 WITH A DISABILITIES ADVOCACY 777 00:35:18,445 --> 00:35:20,947 GROUP, BUT THE GROUP OR 778 00:35:20,947 --> 00:35:22,749 ORGANIZATION DOESN'T HAVE A UEI 779 00:35:22,749 --> 00:35:26,686 NUMBER WHICH IS A UNIQUE ENTITY 780 00:35:26,686 --> 00:35:29,189 IDENTIFIER. AND THEY WANTED TO 781 00:35:29,189 --> 00:35:32,392 KNOW HOW THEY WOULD THEN BUDGET 782 00:35:32,392 --> 00:35:35,095 TO PAY THE ORGANIZATION. SO I 783 00:35:35,095 --> 00:35:37,164 REACHED OUT THE OUR BUDGET 784 00:35:37,164 --> 00:35:37,998 OFFICE. MY INITIAL ANSWER WAS 785 00:35:37,998 --> 00:35:41,168 THAT THEY WOULD HAVE TO HAVE A 786 00:35:41,168 --> 00:35:43,336 UEI NUMBER AND THAT'S THE POLICY 787 00:35:43,336 --> 00:35:47,607 SO IF AN ORGANIZATION IS TO 788 00:35:47,607 --> 00:35:49,910 RECEIVE A SUBCONTRACT UNDER 789 00:35:49,910 --> 00:35:51,244 FEDERALLY FUNDED GRANT, THEY 790 00:35:51,244 --> 00:35:55,749 WOULD HAVE TO HAVE A EUI NUMBER. 791 00:35:55,749 --> 00:35:58,718 HOWEVER, IF THEY DO HAVE A UEI 792 00:35:58,718 --> 00:36:01,121 NUMBER IT CAN BE BUDGETED AS A 793 00:36:01,121 --> 00:36:02,556 FEE FOR SERVICE. SO I WANTED 794 00:36:02,556 --> 00:36:05,559 TO -- I THOUGHT I WOULD VISIT 795 00:36:05,559 --> 00:36:07,394 THAT FOR THE BENEFIT OF THOSE 796 00:36:07,394 --> 00:36:10,730 WHO MAY BE IN THAT SITUATION 797 00:36:10,730 --> 00:36:13,366 WHERE THE ORGANIZATIONS THEY'RE 798 00:36:13,366 --> 00:36:16,636 WORKING WITH DON'T HAVE A UEI 799 00:36:16,636 --> 00:36:16,903 NUMBER. 800 00:36:16,903 --> 00:36:17,504 >> GREAT COMMENT. THANK YOU, 801 00:36:17,504 --> 00:36:21,708 TOYIN. OKAY. WE'RE SEEING 802 00:36:21,708 --> 00:36:27,247 GENERAL EXCITEMENT ABOUT THIS 803 00:36:27,247 --> 00:36:29,316 OPPORTUNITY. ARE ALL METHODS 804 00:36:29,316 --> 00:36:34,754 ALLOWABLE? CAN STUDIES BE 805 00:36:34,754 --> 00:36:35,455 QUALITA 806 00:36:35,455 --> 00:36:36,122 QUALITATIVE? AGAIN, IT IS UP TO 807 00:36:36,122 --> 00:36:39,793 EACH INDIVIDUAL PI AND THEIR 808 00:36:39,793 --> 00:36:41,461 TEAM AND THE PROJECT, THE 809 00:36:41,461 --> 00:36:44,364 QUESTION BEING, YOU KNOW, 810 00:36:44,364 --> 00:36:47,200 ADDRESSED TO SELECT THE MOST 811 00:36:47,200 --> 00:36:49,236 APPROPRIATE STUDY, DESIGN AND 812 00:36:49,236 --> 00:36:52,205 THEN TO DEFEND THAT. SO WE'RE 813 00:36:52,205 --> 00:36:57,944 NOT PRESCRIBING ANY PARTICULAR 814 00:36:57,944 --> 00:37:02,749 TYPE OF STUDY. OKAY. WE GOT A 815 00:37:02,749 --> 00:37:04,351 QUESTION ABOUT INTERNATIONAL 816 00:37:04,351 --> 00:37:11,458 RESEARCH. SO WE HAVE LIMITED 817 00:37:11,458 --> 00:37:14,995 THIS RFA TO DOMESTIC APPLICANTS. 818 00:37:14,995 --> 00:37:21,101 BUT YOU CAN HAVE FOREIGN 819 00:37:21,101 --> 00:37:22,269 SUBCONTRACTS. I THINK THERE 820 00:37:22,269 --> 00:37:24,170 ARE, YOU KNOW, SOME CASES WHERE, 821 00:37:24,170 --> 00:37:26,106 YOU KNOW, ABLEISM IS UNIVERSAL 822 00:37:26,106 --> 00:37:28,341 AND OTHERS WHEN IT'S SPECIFIC TO 823 00:37:28,341 --> 00:37:31,144 THE U.S. SO I WOULD JUST BE 824 00:37:31,144 --> 00:37:34,581 VERY MINDFUL THAT, YOU KNOW, 825 00:37:34,581 --> 00:37:37,651 FOREIGN STUDIES SHOULD HAVE 826 00:37:37,651 --> 00:37:38,451 APPLICABILITY TO THE U.S. 827 00:37:38,451 --> 00:37:43,957 POPULATION TO HAVE PRIORITY 828 00:37:43,957 --> 00:37:54,501 HERE. FOR THIS PARTICULAR RFA. 829 00:37:57,837 --> 00:37:59,472 MORIA, DID YOU WANT TO ADD 830 00:37:59,472 --> 00:38:00,507 ANYTHING OR CHRISTIAN? 831 00:38:00,507 --> 00:38:02,309 >> I -- I DON'T HAVE ANYTHING. 832 00:38:02,309 --> 00:38:05,445 THIS IS MORIA SPEAKING. I DON'T 833 00:38:05,445 --> 00:38:09,182 HAVE ANYTHING ADDITIONAL. JUST 834 00:38:09,182 --> 00:38:11,751 REITERATING THAT WE ARE HERE TO 835 00:38:11,751 --> 00:38:14,154 HELP YOU AND BOTH, YOU KNOW, 836 00:38:14,154 --> 00:38:15,789 REGARDLESS OF IF IT'S A FIT FOR 837 00:38:15,789 --> 00:38:17,424 THIS FUNDING OPPORTUNITY, WE'RE 838 00:38:17,424 --> 00:38:20,160 ALSO HERE TO FIND A HOME FOR 839 00:38:20,160 --> 00:38:21,594 YOUR RESEARCH, SO DON'T BE 840 00:38:21,594 --> 00:38:26,700 AFRAID OF REACHING OUT TO US. 841 00:38:26,700 --> 00:38:27,634 IF YOU DON'T GET A RESPONSE 842 00:38:27,634 --> 00:38:29,269 RIGHT AWAY DON'T BE AFRAID OF 843 00:38:29,269 --> 00:38:30,370 REACHING OUT TO US AGAIN, 844 00:38:30,370 --> 00:38:32,072 BECAUSE OUR HOPE IS TO RESPOND 845 00:38:32,072 --> 00:38:33,707 QUICKLY TO EVERYONE, BUT WE'RE 846 00:38:33,707 --> 00:38:35,875 HUMAN AND SOMETIMES MISS THINGS 847 00:38:35,875 --> 00:38:39,245 AS WELL. THANKS. 848 00:38:39,245 --> 00:38:42,916 >> THANKS MORIA. 849 00:38:42,916 --> 00:38:45,685 >> SO I ACTUALLY -- I APOLOGIZE 850 00:38:45,685 --> 00:38:49,189 THAT I DID NOT DESCRIBE MYSELF 851 00:38:49,189 --> 00:38:53,193 INITIALLY. I AM BEYOND MIDDLE 852 00:38:53,193 --> 00:38:56,796 AGED. I'M WEARING CAUCASIAN 853 00:38:56,796 --> 00:38:58,064 OLDER WOMAN. I HAVE LONG HAIR 854 00:38:58,064 --> 00:39:02,736 AND I'M WEARING A PONYTAIL TODAY 855 00:39:02,736 --> 00:39:04,371 WEARING GLASSES AND A DARK BLUE 856 00:39:04,371 --> 00:39:07,507 SHIRT AND I ACTUALLY JUST SEE A 857 00:39:07,507 --> 00:39:09,109 QUESTION UP ASKING ABOUT WHETHER 858 00:39:09,109 --> 00:39:10,910 WE WILL HAVE SCHOLARS WITH 859 00:39:10,910 --> 00:39:12,379 DISABILITIES THAT WILL BE 860 00:39:12,379 --> 00:39:16,850 INCLUDED IN THE APPLICATION 861 00:39:16,850 --> 00:39:18,518 REVIEW. SO MY INITIAL RESPONSE 862 00:39:18,518 --> 00:39:23,790 TO THAT IS THAT WE ACTUALLY HAVE 863 00:39:23,790 --> 00:39:27,060 NO WAY OF RECRUITING REVIEWERS 864 00:39:27,060 --> 00:39:33,099 THROUGH THE TYPICAL NIH FASHION 865 00:39:33,099 --> 00:39:34,734 OR SYSTEM WHERE INDIVIDUALS ARE 866 00:39:34,734 --> 00:39:39,406 ACTUALLY IDENTIFIED AS HAVING A 867 00:39:39,406 --> 00:39:43,143 DISABILITY. IF WE ARE AWARE OF 868 00:39:43,143 --> 00:39:45,779 INDIVIDUALS IN THE COMMUNITY 869 00:39:45,779 --> 00:39:47,981 THAT HAVE THE SCIENTIFIC 870 00:39:47,981 --> 00:39:50,150 EXPERTISE TO EVALUATE 871 00:39:50,150 --> 00:39:52,385 APPLICATIONS THAT ARE SUBMITTED 872 00:39:52,385 --> 00:39:55,522 THAT DO HAVE DISABILITIES, I 873 00:39:55,522 --> 00:39:57,657 MEAN, THEY WOULD BE OF COURSE 874 00:39:57,657 --> 00:39:58,892 RECRUITED JUST AS ANYONE ELSE 875 00:39:58,892 --> 00:40:03,963 THAT HAS AGAIN, THE SCIENTIFIC 876 00:40:03,963 --> 00:40:05,398 EXPERTISE. 877 00:40:05,398 --> 00:40:08,034 >> I WILL SAY THAT PROGRAM IS 878 00:40:08,034 --> 00:40:09,936 GOING TO WORK WITH REVIEW ON 879 00:40:09,936 --> 00:40:11,938 THIS TO HELP THEM IDENTIFY 880 00:40:11,938 --> 00:40:14,107 REVIEWERS BECAUSE WE DON'T HAVE 881 00:40:14,107 --> 00:40:17,577 ACCESS TO THAT INFORMATION. BUT 882 00:40:17,577 --> 00:40:20,613 WE KNOW MANY OF YOU AND WE KNOW 883 00:40:20,613 --> 00:40:22,549 THAT THIS IS REALLY IMPORTANT SO 884 00:40:22,549 --> 00:40:26,386 WE -- WE SHARE THAT. WE ARE 885 00:40:26,386 --> 00:40:27,687 WORKING ON IT BUT WE'RE NOT 886 00:40:27,687 --> 00:40:30,757 GOING TO BE ABLE TO GIVE A 887 00:40:30,757 --> 00:40:34,360 REPORT AT THE END THAT SHOWS THE 888 00:40:34,360 --> 00:40:37,964 NUMBER OF PEOPLE WITH DISABILITY 889 00:40:37,964 --> 00:40:40,366 ON THE REVIEW PANEL IN PART 890 00:40:40,366 --> 00:40:42,469 BECAUSE IT'S GOING TO BE AN 891 00:40:42,469 --> 00:40:43,736 AGGREGATE REVIEW ROSTER THAT'S 892 00:40:43,736 --> 00:40:47,273 GOING TO INCLUDE PEOPLE FROM ALL 893 00:40:47,273 --> 00:40:50,477 OF THE NICHD SECTS, THAT ROUND. 894 00:40:50,477 --> 00:40:52,212 SO IT'S PROBABLY GOING TO HAVE 895 00:40:52,212 --> 00:40:53,880 HUNDREDS OF NAMES ON IT, WHICH 896 00:40:53,880 --> 00:40:57,684 IS NIH POLICY. BUT WE ASSURE 897 00:40:57,684 --> 00:40:59,185 YOU WE'RE WORKING WITH REVIEW 898 00:40:59,185 --> 00:41:03,223 AND WE KNOW IT'S IMPORTANT. 899 00:41:03,223 --> 00:41:06,659 OKAY. AND THEN WE HAVE A 900 00:41:06,659 --> 00:41:07,660 QUESTION ABOUT RESUBMISSIONS 901 00:41:07,660 --> 00:41:09,963 THROUGH OTHER CHANNELS. YES, SO 902 00:41:09,963 --> 00:41:13,133 IF AN APPLICATION IS NOT 903 00:41:13,133 --> 00:41:17,904 SELECTED FOR FUNDING, THEN 904 00:41:17,904 --> 00:41:19,572 PLEASE USE THE REVIEW, THE 905 00:41:19,572 --> 00:41:21,274 FEEDBACK FROM THE SUMMARY 906 00:41:21,274 --> 00:41:23,009 STATEMENT, REACH OUT TO YOUR 907 00:41:23,009 --> 00:41:24,611 PROGRAM OFFICER AND THEY CAN 908 00:41:24,611 --> 00:41:27,914 WORK WITH YOU ON HOW TO 909 00:41:27,914 --> 00:41:31,017 REPACKAGE IT, ADDRESS REVIEWERS' 910 00:41:31,017 --> 00:41:33,353 CONCERNS, AND COME BACK THROUGH 911 00:41:33,353 --> 00:41:43,897 OTHER OPPORTUNITIES. OKAY. DO 912 00:41:48,001 --> 00:41:50,003 EARLY INVESTIGATORS HAVE AN 913 00:41:50,003 --> 00:41:52,338 ADVANTAGE IN THIS APPLICATION? 914 00:41:52,338 --> 00:41:54,674 SO WE LOVE TO SEE APPLICATIONS 915 00:41:54,674 --> 00:42:01,581 FROM EARLY STAGE INVESTIGATORS. 916 00:42:01,581 --> 00:42:04,017 TYPICALLY THAT IS ONE OF THE 917 00:42:04,017 --> 00:42:06,252 CONSIDERATIONS THAT WE WILL USE 918 00:42:06,252 --> 00:42:08,821 AS PROGRAM OFFICERS IN MAKING 919 00:42:08,821 --> 00:42:12,926 FUNDING DECISIONS. IT'S NOT 920 00:42:12,926 --> 00:42:16,329 GOING TO BE LIKE IN SOME ICS FOR 921 00:42:16,329 --> 00:42:18,731 THEIR PARENT ANNOUNCEMENTS HAVE 922 00:42:18,731 --> 00:42:19,599 DIFFERENTIAL PAY LINES THAT I 923 00:42:19,599 --> 00:42:22,569 CAN SAY WE'RE GOING TO GIVE ESIS 924 00:42:22,569 --> 00:42:24,370 AN EXTRA FIVE POINTS BECAUSE 925 00:42:24,370 --> 00:42:28,374 THIS IS A SPECIAL ONE-TIME 926 00:42:28,374 --> 00:42:31,811 APPLICATION PROCESS. BUT ESI 927 00:42:31,811 --> 00:42:32,845 STATUS IS SOMETHING THAT WE TAKE 928 00:42:32,845 --> 00:42:43,323 A LOOK AT, YES. OKAY. Q&A 929 00:42:49,095 --> 00:42:52,498 SEEMS QUIET. I'LL GIVE IT ONE 930 00:42:52,498 --> 00:42:58,004 MORE MINUTE. AND OF COURSE IF 931 00:42:58,004 --> 00:42:59,706 WE TURN THIS OFF AND YOU THINK 932 00:42:59,706 --> 00:43:03,543 OF SOMETHING, YOU GUYS HAVE 933 00:43:03,543 --> 00:43:04,377 TROYEN'S E-MAIL AND YOU CAN 934 00:43:04,377 --> 00:43:08,381 FOLLOW UP WITH HIM. 935 00:43:08,381 --> 00:43:10,350 >> ABSOLUTELY. AGAIN, I WANT 936 00:43:10,350 --> 00:43:15,855 TO -- I WANT TO THANK CHRISTIAN, 937 00:43:15,855 --> 00:43:18,625 MORIA AND OF COURSE TERESA FOR 938 00:43:18,625 --> 00:43:21,728 JOINING THE DISCUSSION AND THE 939 00:43:21,728 --> 00:43:24,197 PRESENTATION. I ALSO WANT TO 940 00:43:24,197 --> 00:43:25,798 NOTE THAT THE RFA DOESN'T MARK 941 00:43:25,798 --> 00:43:27,600 THE BEGINNING AND THIS IS WHAT 942 00:43:27,600 --> 00:43:29,402 I'VE TOLD ALL THE TEAMS I'VE MET 943 00:43:29,402 --> 00:43:31,671 WITH. DOESN'T MARK THE 944 00:43:31,671 --> 00:43:32,805 BEGINNING OR END OF INTEREST IN 945 00:43:32,805 --> 00:43:35,508 THE TOPIC. SO PLEASE CONTINUE 946 00:43:35,508 --> 00:43:37,510 TO ENGAGE. FEEL FREE TO REACH 947 00:43:37,510 --> 00:43:40,713 OUT IF YOU HAVE QUESTIONS AS YOU 948 00:43:40,713 --> 00:43:42,915 PUT YOUR TEAMS TOGETHER AND 949 00:43:42,915 --> 00:43:45,051 DRAFT YOUR APPLICATION. I WANT 950 00:43:45,051 --> 00:43:47,887 TO THANK THE TECHNICAL SUPPORT 951 00:43:47,887 --> 00:43:50,356 TEAM FOR MAKING THIS MEETING 952 00:43:50,356 --> 00:43:52,659 HAPPEN. AND WE'LL CLOSE THE 953 00:43:52,659 --> 00:43:56,596 WEBINAR. 954 00:43:56,596 --> 00:44:06,839 THANK YOU.